<DOC>
	<DOCNO>NCT00001215</DOCNO>
	<brief_summary>The purpose study identify genetic , biochemical , clinical factor associate disease severity people Gaucher disease lysosomal storage disorder . There vast spectrum clinical manifestation people Gaucher disease well lysosomal storage disorder . This study evaluate patient lysosomal disorder outpatient inpatient basis order well characterize clinical , genetic , pathophysiological feature disorder . Participants re-evaluated annual basis .</brief_summary>
	<brief_title>Genetic Studies Lysosomal Storage Disorders</brief_title>
	<detailed_description>There vast spectrum clinical manifestation encounter individual lysosomal storage disease . Lysosomes organelles involve degradation intracellular protein , recycle product organelle cell . Lysosomal storage disorder occur enzyme necessary breaking molecule deficient , , result , substrate accumulates within lysosome cell may affect different organ system . This longitudinal natural history study patient Gaucher disease storage disorder . Gaucher disease , common lysosomal storage disorder , result inherit deficiency enzyme glucocerebrosidase , break lipid glucocerebroside . The disease characterize extremely variable phenotype , patient present childhood virtually complications Gaucher disease , others remain asymptomatic eighth decade . Often patient Gaucher disease develop hepatosplenomegaly , anemia , thrombocytopenia bony problem . Gaucher disease traditionally divide three clinical subtypes , delineate absence presence neurologic involvement progression : Type 1 -Non-neuronopathic form &lt; TAB &gt; Type 2 -Acute neuronopathic form &lt; TAB &gt; Type 3 -Chronic neuronopathic form Some patient , however , defy classification three category , may accurate regard Gaucher disease continuum phenotypes..In addition , patient carrier Gaucher disease increase risk develop Parkinson disease relate disorder . Our goal study identify genetic , biochemical , clinical parameter associate disease severity individual lysosomal storage disorder , identify mild phenotypic manifestation relative , explore natural history extent associate clinical manifestation . We also want investigate pre-motor manifestation subject high risk develop parkinsonism could contribute early diagnosis . Participants evaluate NIH well characterize clinical , genetic pathophysiological feature disorder . In order well understand entire effect enzyme deficiency function specific protein involve , emphasis place individual atypical presentation . In particular , focus subject Gaucher disease parkinsonism , good understand association two disorder . Following initial comprehensive workup , participant study either inpatient ward outpatient clinic , re-evaluated periodic interval longitudinally .</detailed_description>
	<mesh_term>Gaucher Disease</mesh_term>
	<mesh_term>Lysosomal Storage Diseases</mesh_term>
	<criteria>INCLUSION CRITERIA : Participants must find carrier document lysosomal storage disorder family member document proband .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>March 1, 2017</verification_date>
	<keyword>Lysosomal Storage Disorders</keyword>
	<keyword>Variants</keyword>
	<keyword>Chemical Phenotype</keyword>
	<keyword>Proteins</keyword>
	<keyword>Genes</keyword>
	<keyword>Phenotype</keyword>
	<keyword>Mutations</keyword>
	<keyword>Parkinsonism</keyword>
</DOC>